Kidney Stone Management Market Report 2026

The kidney stone management market size has grown strongly in recent years. It will grow from $2.46 billion in 2025 to $2.62 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing prevalence of kidney stone disease, improvements in imaging-based diagnostics, wider availability of lithotripsy systems, expansion of urology specialty services, growing patient awareness of treatment options.

The kidney stone management market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing adoption of micro and mini pcNL techniques, rising demand for outpatient urology procedures, expansion of precision diagnostics in stone analysis, growing focus on preventive stone management, increasing investments in advanced urology devices. Major trends in the forecast period include increasing adoption of minimally invasive stone removal procedures, rising use of disposable ureteroscopes, growing integration of advanced imaging in diagnostics, expansion of outpatient stone treatment services, enhanced focus on stone recurrence prevention.

The increasing prevalence of chronic kidney disease (CKD) is expected to drive the growth of the kidney stone management market in the coming years. Chronic kidney disease refers to the gradual loss of kidney function over time and is commonly caused by conditions such as diabetes, high blood pressure, and genetic factors. The rise in CKD cases is largely attributed to the growing prevalence of diabetes, which is a major contributor to long-term kidney damage. Kidney stone management supports individuals with CKD by preventing urinary blockages and infections, thereby protecting the kidneys from further damage and helping preserve renal function. For example, in June 2024, the Australian Institute of Health and Welfare reported that chronic kidney disease accounted for 1.1% of the total burden of disease in Australia in 2024. This indicates that the increasing prevalence of CKD is contributing to the growth of the kidney stone management market.

The growing adoption of robotic-assisted surgeries is expected to propel the growth of the kidney stone management market going forward. Robotic-assisted surgery is a minimally invasive approach in which surgeons use computer-controlled robotic systems to perform highly precise and controlled procedures. The rise in robotic-assisted surgeries is driven by improved surgical precision, as these systems enable greater accuracy and control during complex interventions. Kidney stone management contributes to this trend by allowing surgeons to treat complex stones with enhanced precision, resulting in better patient outcomes. For instance, in January 2025, Intuitive Surgical Inc. reported that its customers performed nearly 2.7 million procedures in 2024, representing a 17% increase compared to 2023 and bringing cumulative procedures on da Vinci platforms to nearly 17 million. During the same year, the company installed 1,430 da Vinci multiport systems, 271 Ion systems, and 96 da Vinci SP systems. This growth demonstrates that the rising adoption of robotic-assisted surgeries is supporting market expansion.

Companies operating in the kidney stone management market are increasingly focused on developing advanced solutions, such as single-use ureteroscopes, to offer comprehensive stone management options for urology practices. The Ascend ureteroscope provides flexible endoscopic access to the urinary tract, including the ureter and kidney, enabling visualization, diagnosis, and treatment of conditions such as kidney stones. For example, in May 2024, Cook Medical Inc., a US-based medical device company, launched the Ascend single-use ureteroscope, a disposable endoscopic device designed for urologic procedures, including kidney stone management. The device features 275-degree up-and-down deflection and a deflection lock that maintains the selected angle, improving precision during challenging procedures. Additionally, the Ascend ureteroscope received approval under Medicare’s Transitional Pass-through payment scheme, increasing its accessibility in clinical settings.

Major companies operating in the kidney stone management market are Medtronic plc, Siemens Healthineers AG, C.R. Bard Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Karl Storz GmbH & Co. KG, Cook Medical Inc., Richard Wolf GmbH, Lumenis Ltd., Dornier MedTech, EDAP TMS S.A., E.M.S. Electro Medical Systems S.A., STORZ MEDICAL AG, Medispec Ltd., DirexGroup SA, Elmed Medical Systems Ltd., Pnn Medical A.S., Allengers Medical Systems Limited, Potent Medical, ROCAMED SAM.

North America was the largest region in the kidney stone management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney stone management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the kidney stone management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the kidney stone management market by increasing costs of imported lithotripters, endoscopic instruments, imaging systems, and disposable accessories used in diagnosis and treatment. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported urology equipment, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are increasing procedure costs and capital expenditure for care providers. At the same time, they are encouraging local production of urology devices, regional supplier development, and adoption of cost-optimized treatment technologies.

The kidney stone management market research report is one of a series of new reports that provides kidney stone management market statistics, including kidney stone management industry global market size, regional shares, competitors with a kidney stone management market share, detailed kidney stone management market segments, market trends and opportunities, and any further data you may need to thrive in the kidney stone management industry. This kidney stone management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Kidney stone management encompasses a comprehensive medical approach focused on diagnosing, monitoring, and treating the formation and presence of solid mineral deposits in the kidneys. It includes strategies to alleviate symptoms, remove existing stones, and prevent recurrence by considering factors such as stone composition, size, location, and the patient’s overall health status.

The primary treatment options for kidney stone management include extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, percutaneous nephrolithotomy (PCNL), and others. ESWL is a non-invasive therapeutic procedure that uses high-energy shock waves generated outside the body to fragment stones in the kidney, ureter, or other ducts into smaller pieces. Key product types used in kidney stone management include lithotripters, stone removal baskets, ureteral stents, and ureterorenoscopes. Diagnosis is performed using techniques such as abdominal X-rays, computed tomography scans, ultrasound, abdominal MRI, intravenous pyelography, and other methods. These products and services are distributed through retail pharmacies, online pharmacies, and other channels and are utilized by end users including hospitals, specialty clinics, ambulatory surgical centers, and other healthcare facilities.

The kidney stone management market consists of revenues earned by entities by providing services such as advanced diagnostic services, minimally invasive treatment procedures, medical consultations and therapeutic interventions, post-procedure care, and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney stone management market also includes sales of stone retrieval devices, ureteral stents, and catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.